PH12016500500A1 - A viral vaccine and methods of manufacture thereof - Google Patents

A viral vaccine and methods of manufacture thereof

Info

Publication number
PH12016500500A1
PH12016500500A1 PH12016500500A PH12016500500A PH12016500500A1 PH 12016500500 A1 PH12016500500 A1 PH 12016500500A1 PH 12016500500 A PH12016500500 A PH 12016500500A PH 12016500500 A PH12016500500 A PH 12016500500A PH 12016500500 A1 PH12016500500 A1 PH 12016500500A1
Authority
PH
Philippines
Prior art keywords
manufacture
methods
virus
viral vaccine
culture
Prior art date
Application number
PH12016500500A
Other languages
English (en)
Inventor
Vadrevu Krishna Mohan
Ramasamy Venkatesan
Duvvuru Prasanna Kumar
Original Assignee
Bharat Biotech Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Biotech Int Ltd filed Critical Bharat Biotech Int Ltd
Publication of PH12016500500A1 publication Critical patent/PH12016500500A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PH12016500500A 2013-09-14 2016-03-14 A viral vaccine and methods of manufacture thereof PH12016500500A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000585 WO2015059714A1 (fr) 2013-09-14 2014-09-08 Mode d'urgence dans un véhicule hybride
IN4135CH2013 IN2013CH04135A (fr) 2013-09-14 2014-09-08

Publications (1)

Publication Number Publication Date
PH12016500500A1 true PH12016500500A1 (en) 2016-06-13

Family

ID=52997726

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500500A PH12016500500A1 (en) 2013-09-14 2016-03-14 A viral vaccine and methods of manufacture thereof

Country Status (6)

Country Link
CN (1) CN105744952A (fr)
AU (1) AU2014338520B2 (fr)
IN (1) IN2013CH04135A (fr)
PH (1) PH12016500500A1 (fr)
RU (1) RU2706693C2 (fr)
WO (1) WO2015059714A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
US11162880B2 (en) 2015-11-09 2021-11-02 University Of Notre Dame Du Lac Particle size purification method and devices
EP3464565A4 (fr) 2016-05-25 2020-01-01 Terumo BCT, Inc. Expansion cellulaire
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
EP3703741A1 (fr) 2017-11-03 2020-09-09 Takeda Vaccines, Inc. Vaccins et compositions immunogènes anti-zika, et leurs procédés d'utilisation
BR112020009960A2 (pt) 2017-11-30 2020-11-10 Takeda Vaccines, Inc. método para a inativação de vírus zika e métodos relacionados
EP3581646A1 (fr) * 2018-06-15 2019-12-18 Themis Bioscience GmbH Système chromatographique et de fabrication intégré pour la production de virus
CN111394321A (zh) * 2020-03-30 2020-07-10 无锡加莱克色谱科技有限公司 病毒颗粒纯化用超大孔径层析介质及其应用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1604685T3 (da) * 1997-08-28 2012-06-18 Cj Cheiljedang Corp Et svækket japansk encephalitisvirus
WO2010137036A2 (fr) * 2009-05-25 2010-12-02 Panacea Biotec Ltd Nouveau vaccin contre l'encéphalite japonaise et procédé de fabrication correspondant
CN102100910B (zh) * 2009-12-21 2013-01-23 北京清大天一科技有限公司 一种生产病毒疫苗的方法
WO2012073257A2 (fr) * 2010-11-30 2012-06-07 Bharat Biotech International Limited Formulations vaccinales pour la prophylaxie et le traitement d'infections par le virus chandipura chez les mammifères
US9580692B2 (en) * 2012-02-29 2017-02-28 Ge Healthcare Bioprocess R&D Ab Method for endotoxin removal

Also Published As

Publication number Publication date
WO2015059714A8 (fr) 2015-06-18
RU2016114285A (ru) 2017-10-19
RU2016114285A3 (fr) 2018-07-16
RU2706693C2 (ru) 2019-11-20
CN105744952A (zh) 2016-07-06
AU2014338520B2 (en) 2019-12-05
IN2013CH04135A (fr) 2015-08-14
WO2015059714A1 (fr) 2015-04-30
AU2014338520A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
PH12016500500A1 (en) A viral vaccine and methods of manufacture thereof
PH12018501602A1 (en) Subunit immersion vaccines for fish
PH12018500855A1 (en) Herpes simplex virus vaccine
EP3551193A4 (fr) Vaccins à acide nucléique contre des virus respiratoires
PH12015501526A1 (en) Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same
EP4272746A3 (fr) Formes cristallines de bêta-nicotinamide mononucléotide
MX2018004916A (es) Vacuna contra el virus de la influenza de amplio espectro.
MX2018010483A (es) Inmunogenos para vacunacion contra vih.
MX349119B (es) Vacuna de virus de dengue inactivado.
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
WO2015052543A3 (fr) Vaccination antipaludique
MY191539A (en) Streptococcal vaccine
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
MX2016014868A (es) Metodos para secar por congelacion y rehidratar productos biologicos.
MX2019007252A (es) Metodos y composiciones para vacunas del virus del dengue.
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
MX2019007924A (es) Vacunas contra la influenza.
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie
WO2014174532A3 (fr) Procédé amélioré pour la préparation d'emtricitabine
UA59897U (ru) Способ изготовления вакцины против бешенства животных "рабизин"
IN2013MU03638A (fr)